Logronio, Rudy .

HRN: 28-85-83  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/15/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/15/2026
04/22/2026
IV
500 Mg
Q8
Acute Appendicitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: